Page last updated: 2024-11-02

pamidronate and Hypophosphatemia

pamidronate has been researched along with Hypophosphatemia in 4 studies

Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.

Research Excerpts

ExcerptRelevanceReference
"Fibrous dysplasia of bone is a genetic, non-inheritable disease, characterized by bone pain, bone deformities and fracture, involving one or several bones."2.44Fibrous dysplasia of bone and McCune-Albright syndrome. ( Chapurlat, RD; Orcel, P, 2008)
"McCune-Albright syndrome (MAS) is sometimes complicated by hypophosphatemia and abnormally low levels of 1,25(OH)(2)D in the presence of hypophosphatemia."1.33The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. ( Imanishi, Y; Inaba, M; Jüppner, H; Kinoshita, E; Koshiyama, H; Miyauchi, A; Nakagomi, Y; Nishizawa, Y; Ozono, K; Satomura, K; Shimizu, N; Yamamoto, T, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Imanishi, Y1
Kinoshita, E1
Nakagomi, Y1
Shimizu, N1
Miyauchi, A1
Satomura, K1
Koshiyama, H1
Inaba, M1
Nishizawa, Y1
Jüppner, H1
Ozono, K1
Chapurlat, RD1
Orcel, P1
Kutluk, T1
Akyüz, C1
Yalçin, B1
Varan, A1
Büyükpamuküçu, M1
Elisaf, M1
Kalaitzidis, R1
Siamopoulos, KC1

Reviews

1 review available for pamidronate and Hypophosphatemia

ArticleYear
Fibrous dysplasia of bone and McCune-Albright syndrome.
    Best practice & research. Clinical rheumatology, 2008, Volume: 22, Issue:1

    Topics: Diphosphonates; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Fractures, Bone; GTP-Bind

2008

Other Studies

3 other studies available for pamidronate and Hypophosphatemia

ArticleYear
The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
    Journal of bone and mineral metabolism, 2005, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Calcium; Child; Diphosphonates; Female; Fibroblast Growth Factor-23; Fibroblast G

2005
Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
    Medical and pediatric oncology, 1998, Volume: 31, Issue:1

    Topics: Antineoplastic Agents; Child; Diphosphonates; Humans; Hypercalcemia; Hypocalcemia; Hypophosphatemia;

1998
Multiple electrolyte abnormalities after pamidronate administration.
    Nephron, 1998, Volume: 79, Issue:3

    Topics: Antineoplastic Agents; Calcium; Calcium Metabolism Disorders; Diphosphonates; Electrolytes; Humans;

1998